Subscribe to Newsletter

Content by James Strachan:

 Manufacture Drug Delivery

Pharma’s Great Green Rush

| Stephanie Vine, James Strachan

What's causing pharma's fascination with cannabinoids and cannabis?
Business & Regulation Quality & Compliance

A Positive-Sum Game

| James Strachan

How important is pharmacovigilance in the post-market safety of drugs?
Business & Regulation Business Practice

What Bad Rep?

| James Strachan

Take a look at the Reputation Institute's ranking of the pharma industry
Manufacture Technology and Equipment

Leidenfrost Nanochemistry

| James Strachan

How volcanoes inspired the fabrication of nanoparticles for cancer treatment
Manufacture Formulation

Pulling for a Cure: Lessons Learned with John Lambert

| James Strachan

John Lambert talks antibody-drug conjugates and his involvement with Kadcyla.
Business & Regulation Business Practice

ABPI Sets Out Its Stall

| James Strachan

The ABPI releases a manifesto for the UK’s upcoming election.
Business & Regulation Biosimilars

WHO Wants Cancer Biosimilars

| James Strachan

Will a pilot project to prequalify “generic” biologics improve safe access to medicines?
Business & Regulation Standards & Regulation

European RAPSody

| James Strachan

With big regulatory changes on the horizon, RAPS invests in Europe.

Manufacture Small Molecules

Hidden Fungi Treasures

| James Strachan

Does Penicillium contain a treasure trove of undiscovered secondary metabolites?
Business & Regulation Business Practice

It’s Just Been Revoked

| James Strachan

PhRMA weeds out 22 members after revising membership rules.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker